{"ticker": {"uuid": "51b64674-3c99-4d55-8b95-eb1d46fe79c4", "symbol": "EW", "name": "Edwards Lifesciences Corp", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors", "summary": "Edwards Lifesciences Corp. (EW) shares fell by 3.13% to $87.27 on Wednesday, marking its third consecutive day of losses. This underperformance occurred despite an overall favorable trading session where the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) both saw gai", "url": "https://www.marketwatch.com/data-news/edwards-lifesciences-corp-stock-underperforms-wednesday-when-compared-to-competitors-bd4046aa-46fd7680d512?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-15T20:39:57", "published_display": "15 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Price Target on Edwards Lifesciences to $105 From $100, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mizuho-adjusts-price-target-edwards-152435167.html", "source_name": "MT Newswires", "published_at": "2026-07-15T15:24:35+00:00", "published_display": "15 Jul 2026 15:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Edwards Lifesciences served $10m penalty over JC Medical acquisition violations", "summary": "", "url": "https://finance.yahoo.com/m/d131a60f-5e0b-3f39-b18c-f9d6bfc55b2e/edwards-lifesciences-served.html", "source_name": "Medical Device Network", "published_at": "2026-07-14T16:32:16+00:00", "published_display": "14 Jul 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day", "summary": "Edwards Lifesciences Corp. (EW) shares fell 1.85% to $90.09 on Tuesday, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index rose 0.38% and the Dow Jones Industrial Average rose 0.02% in an other", "url": "https://www.marketwatch.com/data-news/edwards-lifesciences-corp-stock-outperforms-competitors-despite-losses-on-the-day-ca47763c-ea3fba3c900d?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T16:49:00", "published_display": "14 Jul 2026 16:49", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Adjusts Price Target on Edwards Lifesciences to $94 From $87, Maintains Neutral Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-adjusts-price-target-edwards-114527662.html", "source_name": "MT Newswires", "published_at": "2026-07-14T11:45:27+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $102 From $98, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/goldman-sachs-adjusts-price-target-113955203.html", "source_name": "MT Newswires", "published_at": "2026-07-14T11:39:55+00:00", "published_display": "14 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock reflects its specialized heart-care profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQSGZnRlhaUGhGVV85QzdKMDFlNHBuYjVHUXNPQWEzSlktS21BWnctdExfNlBxMEZMdlI5eFY5TDBJOFpwOHo5UnBLZkk2X3JaR1FUUmx6TFUyOHc4ZFVycVN4cDV3dEdDaEdnWXFrMUFLbzBFZmRCUkoyRkg5TGRUMzFyUnZybDJpR2tzT1h3VHE1Ykk2WW1lYm9LemF2SllZWmJpaUZ2MFY1NnlpNGUtWjVVYmh6emh5TnRRa29MdnltMEQ2cnJpTg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-14T10:50:26+00:00", "published_display": "14 Jul 2026 10:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences, Genesis MedTech to Pay Combined $12M to Settle FTC Charges -- Update", "summary": "Edwards Lifesciences and Genesis MedTech will pay a combined $12 million to settle Federal Trade Commission (FTC) charges related to their previous acquisition activities. The FTC alleged that Edwards Lifesciences acquired Genesis MedTech's heart valve business in 2022, which was", "url": "https://www.moomoo.com/news/post/72881238/edwards-lifesciences-genesis-medtech-to-pay-combined-12m-to-settle?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-13T23:07:59", "published_display": "13 Jul 2026 23:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Edwards Lifesciences Corp For: 13 July By Investing.com", "summary": "This article reports on a Form 4 filing for Edwards Lifesciences Corp (EW) on July 13. Form 4s indicate changes in ownership of company stock by insiders. The article provides the date of the filing but does not detail the specifics of the transactions.", "url": "https://ng.investing.com/news/stock-market-news/form-4-edwards-lifesciences-corp-for-13-july-93CH-2597468", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T21:18:04", "published_display": "13 Jul 2026 21:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards will pay $10M to settle FTC charges of skirting antitrust review", "summary": "", "url": "https://finance.yahoo.com/m/75731ca0-1aa0-3dde-a0b0-3555d48fa739/edwards-will-pay-%2410m-to.html", "source_name": "MedTech Dive", "published_at": "2026-07-13T17:02:14+00:00", "published_display": "13 Jul 2026 17:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Raises Price Target on Edwards Lifesciences to $110 From $100, Keeps Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/rbc-raises-price-target-edwards-115343357.html", "source_name": "MT Newswires", "published_at": "2026-07-13T11:53:43+00:00", "published_display": "13 Jul 2026 11:53", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock reflects steady growth prospects in cardiovascular care", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNSXI5Y3VnTlpMd3RqcVlJOE1SWEo3d0ZFbHd6NkhjQ09TZWhEYzItOGR3VF9NVWx1ZFd4S3UyZ2dhclJwTjloTm1PZDlxWVdVYXZwT2RaNk8xbzhsaVBWekhIZ0c0ODhqdV9JUlZhTEJjbDZWRUp1RE8tbF84aV9mUmtLZkR2czJucWExRWtQVlctcUFteVNkRFZ4SkNQeWp2clJIbG1INk9SQWt1ZXpyT1p5ZjNsT005R3JOS0NR?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-11T22:01:51+00:00", "published_display": "11 Jul 2026 22:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW)", "summary": "Daniel Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), sold 619 shares of the company on July 10, 2026. This transaction leaves him with 40,033.9103 shares. The article also notes that Edwards Lifesciences Corp is currently trading at $91.7, which is fairly valued according ", "url": "https://www.gurufocus.com/news/8954306/insider-sell-daniel-lippis-sells-shares-of-edwards-lifesciences-corp-ew", "source_name": "GuruFocus", "published_at": "2026-07-11T00:46:40", "published_display": "11 Jul 2026 00:46", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Edwards Lifesciences Corp For: 10 July By Investing.com", "summary": "This article reports on a Form 4 filing for Edwards Lifesciences Corp for transactions made on July 10th. Form 4s disclose changes in beneficial ownership of securities by company insiders. The brief news item includes the company's stock symbol (EW) and its performance on the da", "url": "https://ng.investing.com/news/stock-market-news/form-4-edwards-lifesciences-corp-for-10-july-93CH-2595637", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T21:37:40", "published_display": "10 Jul 2026 21:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences CVP sells $56,762 in company stock", "summary": "Daniel J. Lippis, CVP of TAVR at Edwards Lifesciences Corp (NASDAQ:EW), sold 619 shares of company stock for $56,762 after acquiring them through employee stock options. The transactions were conducted under a Rule 10b5-1 trading plan. Following the sale, Mr. Lippis retains over ", "url": "https://www.investing.com/news/insider-trading-news/edwards-lifesciences-cvp-sells-56762-in-company-stock-93CH-4786998", "source_name": "Investing.com", "published_at": "2026-07-10T21:37:35", "published_display": "10 Jul 2026 21:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) CFO receives stock, performance unit and option grants", "summary": "The CFO of Edwards Lifesciences, Theodora Mistras, received new equity awards on July 9, 2026, as part of the company's Long-Term Stock Incentive Compensation Program. These awards include restricted stock units, performance-based restricted stock units, and employee stock option", "url": "https://www.stocktitan.net/sec-filings/EW/form-4-edwards-lifesciences-corp-insider-trading-activity-25726b83c6f1.html", "source_name": "Stock Titan", "published_at": "2026-07-10T21:11:36", "published_display": "10 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) CVP exercises stock options and sells 619 shares", "summary": "Daniel J. Lippis, CVP at Edwards Lifesciences, exercised stock options for 619 shares at $72.68 and immediately sold them at $91.70 per share on July 10, 2026. This transaction was pre-scheduled under a Rule 10b5-1 trading plan adopted in February 2026. Following these trades, Li", "url": "https://www.stocktitan.net/sec-filings/EW/form-4-edwards-lifesciences-corp-insider-trading-activity-f6e5a6847b18.html", "source_name": "Stock Titan", "published_at": "2026-07-10T21:04:34", "published_display": "10 Jul 2026 21:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors", "summary": "Edwards Lifesciences Corp. (EW) stock fell 2.47% on Thursday, closing at $91.33. This underperformance occurred despite a favorable trading session for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both rising. This marks the third consecutive day of", "url": "https://www.marketwatch.com/data-news/edwards-lifesciences-corp-stock-underperforms-thursday-when-compared-to-competitors-aded3bc0-0220a69ba00e", "source_name": "MarketWatch", "published_at": "2026-07-09T20:47:47", "published_display": "09 Jul 2026 20:47", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxObXdOUUozb2RKbXgxcVpKb0c0eVdkWDBqYzQybW1QcE1QSkZZYW1HbmVqMHczT083VENoa2QzNkU1WGprRjRKU2d5MDM1VFRqRVpfZk83VG1vSVl4cURlM3JTUmdWVHFmck5SNmRpUThJRl9GREd6UXJXUWpWdEhhNV9sb0d0WWlBTU5JZjNJS25LZzJCNXJDeDJtN3JKaU1FREhKOF9UVXRqb3dLbDZZdnJQNGZadkVUUmNUS1BfU3hIZTdPWC1OdVhn?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T10:40:27+00:00", "published_display": "09 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EW Maintained by Citigroup -- Price Target Raised to $110", "summary": "Citigroup has maintained a \"Buy\" rating on Edwards Lifesciences (EW) and raised its price target from $101 to $110, indicating confidence in the company's growth opportunities. Despite this positive analyst outlook and a strong GF Score\u2122 of 97/100, the stock is currently consider", "url": "https://www.gurufocus.com/news/8949685/ew-maintained-by-citigroup-price-target-raised-to-110", "source_name": "GuruFocus", "published_at": "2026-07-08T17:07:30", "published_display": "08 Jul 2026 17:07", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) Shares Fresh Valve Data, Is The Stock Too Pricey?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T16:01:20+00:00", "published_display": "08 Jul 2026 16:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citigroup Adjusts Edwards Lifesciences Price Target to $110 From $101", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/citigroup-adjusts-edwards-lifesciences-price-131704289.html", "source_name": "MT Newswires", "published_at": "2026-07-08T13:17:04+00:00", "published_display": "08 Jul 2026 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences focuses on heart valve growth as US cardiac demand stays solid", "summary": "Edwards Lifesciences, a medical technology company, is prioritizing growth in heart valve therapies, especially TAVR, driven by solid demand in the US cardiac procedure market and an aging population. The company's strategy revolves around treating structural heart diseases with ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/edwards-lifesciences-focuses-on-heart-valve-growth-as-us-cardiac-demand/69723943", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T13:08:46", "published_display": "08 Jul 2026 13:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences\u2019 SWOT analysis: stock gains momentum on market share opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNMXA2MGJhcXQ1UVZNOWNoVDlxbTM5ZnBsMzFfNHE2SFBRcFhHOUl3X1U1anVrNF9tYlBXQXo4UnpwT2EzdXhDT3dOOVZXa0lsM2pvSDBGbTM0RWFOakZkRExlbTdPbko2S2lYNExWU3RlLW1xSmZZYnRUSm9NMVg2YUNVQ1lPX0xQRzBoRkV4UnBPVk5aMDJrRUxmaWQtZk1JRjVRaVFCb1FNa0hWak9pZTUyaHF6T3pKZEtXZFRsTldDeU5QN3hpR2tCTWhfb1h3UTZJb1FhTFI?oc=5", "source_name": "Investing.com", "published_at": "2026-07-07T23:13:02+00:00", "published_display": "07 Jul 2026 23:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Edwards Lifesciences Corp For: 7 July By Investing.com", "summary": "This article from Investing.com announces the filing of a Form 4 for Edwards Lifesciences Corp on July 7th. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders when they trade shares in their own company. This filin", "url": "https://ng.investing.com/news/stock-market-news/form-4-edwards-lifesciences-corp-for-7-july-93CH-2590079", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T00:02:00", "published_display": "08 Jul 2026 00:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) executive has shares withheld for tax on vesting", "summary": "Edwards Lifesciences executive Daniel J. Lippis reported a routine disposition of 377 shares of common stock at $95.18 per share. This action was taken to cover tax obligations related to the vesting of equity awards, as per Rule 16b-3(e). After this tax-withholding event, Lippis", "url": "https://www.stocktitan.net/sec-filings/EW/form-4-edwards-lifesciences-corp-insider-trading-activity-10380872e16c.html", "source_name": "Stock Titan", "published_at": "2026-07-07T22:56:40", "published_display": "07 Jul 2026 22:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth prosp", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOdUcxR1cxa3BuRWFDaElVeEtpLXNQa0lFc29IYXVlZ3laT3kyVXF1cGVTVkdXYjlpMjRrV29DbkFfMXRTdHM1WmV0VUxqb3FKX2RLdmNfeW9kbFN4eHZyYkYxMnpfclZsUzZtRGNEMEZWcUtIT3FPQy1YXzZ0UmpTN3ZpOHdBR2phNU1pdzlFdVVHbnVzZHJOcWc5Wi1NZ3lEY0l0NmRQdElaZ1ZabEF4ckEwTXQ0b1pLMVlETGhCWm1yVmlRemRFUkhB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-07T06:57:48+00:00", "published_display": "07 Jul 2026 06:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Adjusts Price Target on Edwards Lifesciences to $100 From $93", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-adjusts-price-target-131101622.html", "source_name": "MT Newswires", "published_at": "2026-07-06T13:11:01+00:00", "published_display": "06 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock leans on its core heart valve business", "summary": "Edwards Lifesciences (US28176E1082) remains focused on its structural heart therapies, particularly its core heart valve franchise. The company's business model relies on transcatheter aortic valve replacement systems and related products, with the SAPIEN family being a key produ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/edwards-lifesciences-stock-leans-on-its-core-heart-valve-business/69703313", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T08:23:52", "published_display": "06 Jul 2026 08:23", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EW - Edwards Lifesciences Corp Volatility & Greeks", "summary": "This article provides a detailed financial overview of Edwards Lifesciences Corp (EW), including its stock performance, market capitalization, income, sales, and various financial ratios. It also presents insider ownership and institutional ownership data, along with volatility m", "url": "https://finviz.com/stock?t=EW&ty=ocv&ta=1&p=d&ov=list_date&e=2026-08-21", "source_name": "Finviz", "published_at": "2026-07-05T22:08:51", "published_display": "05 Jul 2026 22:08", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How New Valve Trial Data and Index Reclassification Will Impact Edwards Lifesciences (EW) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T08:39:36+00:00", "published_display": "05 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Edwards Lifesciences Corp (EW)", "summary": "This article analyzes the historical performance of investing $1,000 in Edwards Lifesciences Corp (EW) over various periods, showing returns ranging from +23.1% in one year to +184.2% over ten years. It also provides a detailed overview of Edwards Lifesciences, a medical technolo", "url": "https://www.stocktitan.net/tools/stock-return-calculator/EW", "source_name": "Stock Titan", "published_at": "2026-07-04T08:37:38", "published_display": "04 Jul 2026 08:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences focuses on heart valve growth. Investors watch structural heart demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQYTFMaXpwQzR5dEZCckJoSERDaU1udGVvVVRSNVlIYVpabk5nVGs5M2lGZEx3ZUgxM0pwUWhmS3BzZnp6OW94REtNZWdadEFRZ2MwSnFoblNQekpkQ3gtRjE5cUtoOGJTcE1TWWNVeXM1dFU5RXFlRWI1aGVqLWlZWWlnaWQyU1V3U3RJd3J5MnZtR1JoQjRlYlZnM251VlRLaFFaeVVoS3hCRWJlNFV0SXd5TmwwLVZfZzQxbGw1U25iV2s?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T10:50:42+00:00", "published_display": "03 Jul 2026 10:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOLU0tWE5MT21oOEJ1YlhNbzgzYTBRM0szdFkxTi0zQTdKUk9VUnI5Z0wwbW9sZHR2Z1VscTkyTE9vc1ViVHRyekRPc2g2dmpVeWstcGs0RkZVZW9UVURIQkdtZEVEVFV5ZXR1RWMwelZkXzBpNVJsUlNxTEpLUnpjaTAwRmxHY3pYQzVtNnRjNF9yaC1IVWhZa1NqOEUtaFlyN0JHNkpqblZ2Y0VkQmZfVTM4RUwyWkN2?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) Stock Weighs DCF Fair Value Against High P/E Multiple", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards brings fresh valve data to New York, with TAVR study update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQ2pGVVRySmVSeUVWVVFwZngxdkQ3UE82Y3E1RmtYZFZVc2Y0eXVpVnVwZTBKenZ2Ti1VM1BncV9zWWdqTDQwUnlFUDktN01UTExBTjNNV0ppQUtEVUtLTVpMUVMyTmdPV2ZLTFVRSldGR3MzS241VmVOTE9ubC1fSEwyZENJd3Zzck0wbVNNV19PaFJhTkc0S2trLXh5bXF3eklYUlM4SXVNczVucXM0OHVPVWpPUWl0NFZj?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Edwards Lifesciences stock climbing today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPN3NTd2lKT3RnTjJoUl9aRUhfbi13U3ZEdHBaaDhjSS0tQ2NxeU5RVERGNTJlNHpCVzFGWVpLb25wUWUteXgzemViTVFCVDlxcDluQnRJT2JZcFFkcm15T2dvTTdXXzFpVlRfWHhTcFBhVG1YVTZoNTlJWTk0dG53M2VibE00Q0ZqY0trYV9lZjBYYUx0ZlFIVlExQWNYX2Etd1A1NHhzRlJiaDhFMldz?oc=5", "source_name": "Investing.com", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Edwards Lifesciences Stock (US28176E1082): Valuation metrics under the microscope", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQbWpXRkstZjUzYU5GVVRtS3hYNDZ0dXhlb0FaS1FWU3VCWU5pNXJKd1lVRWMyVlRSajJ0Slp2NWhGalJqQ3dpVnc1OFhJV3ZiMU5vZElkWHh4Zi0yNW5fZ05UMk1wMW1VbFpMbkVuRDRhUTBpOXROd3g0ZGczaGp4MTQ1MEg4bDBXQ1N1WHlXZEpmX1EtbjNRN2tKaEpLcU84YmR0UkxEV1U1c0twMEVlOTdXYTEwNEMwREtNN3A0UzRvd1hf?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPSFNyMnNsYWo0VFpRRm15ekVtRDNXbHE0ZHZpQUtWS1o3RUJxZUtDcEdWUzc1VHlEd04tdW80WGpITUwwazlhNGhiS0tVa3NvaXdMQ25JWDZQdXNsRWVyclFDUzZPaGp3RzRZNGdBRGpMdlZpZk53akRCbVBFLWlKQzJQSkZBUTA4cTk3TmZ5S0d0TkRmQmpKSGFKQWNRN2hEUGltX2U4Q1lKdTNKUVNv?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock (US28176E1082): NYSE-listed medtech share edges lower as investors digest", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPQ21HWW9tRm04NVhGSGg3aF96T2s5dXhLQ3EwNjJsVDc2UE5xV0pwZGdaVkw5U3F0c05ZdlJGNGNmV3lIRWhvVE9LS1dJdkx2U0RoS2dmWGlkbTZpd3liYy1BaGh6M19sMTVJSnpVZHc1anZWa2N0Y2xLMVJfdk4tT1ByUnpkMjFvb2hkUkVJbHd2NWx4Z0hPaXMxQ0MybXNZLVNkVEhfTUNWZjZyLVZLN1hPZDRLUGtQaHhmSzVkWXNoczExWGwyLWF3?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPM3FMVXZjanB3aFlDNV9ad29xWDM3OUJHd0dtTGFaRnhvOTRndUlQR2Iwb3lyT2tYSDZ4T1g2eFNCdHp1UFM0Z1RENlNxWk8yZnFRdUtzemQxYlJocXdQUzZwOUFyV3p6U2U3OVpPeU5xRXpuYXJ2ZGJqcURLWTdnOF9tNGxZMkd3dTREUUZ5ZjZvdUhKcTFpX2ZXcDZDWGdvZmxINg?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Edwards Lifesciences stock (US28176E1082): heart-valve specialist in focus after latest earnings upd", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPTkhWajJYRzFZY20tSms3Y1BaT0NtSjh6MWJjVl9RWi1GZVhxVVdILWFvS0pXcHV6NDBibkpPNS00eG5fd2Z4X0pJa2ZjdnZ0LVVPZ0g2cEJWQXVUZmJRMDVLRUFDcEtjVDhQMEluTFdCaVh4cmNaSUJ2Vkd6Z2ZfM2FXNzhON0NBaG5PelR0U183a3JMVFhOUGdEaGRFOExOdXQ1TnNDNHhfblZLaGkwQUhIMmE3TG9ZT19sWEN5Q2MyVl81RTI3aFV3?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNHk2djRZbXd0ekVhdWpfZ1FPamYwU0tMQy1mT3N4Tm9hWnJ3NzRJMVNjMnFJVHRIU1NzV1h3VTFwVEtDN0ZNV1hEMHVtdkk0VTI1ckNweUR5eHduSnFlb0Y3bFJDNlVnY2ZsSGhNY1IwZ1I0Q1hORHFaVEE1R1FXRWxMUmtjOWdUTjJuWUw3QktMRXQwa1RyaXkycVE1Q19VTzJoa0tEbndUa00?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOdTBGTnJfMDl5NUNzRDZ0LTFEME9nRFBwXzM1RERqRXphUjg3c19BZ3lJSV9wU0FvTVBpVWdfZm1lRmZ5TGtxWXplNmRrRFEzTkJKUHFqMkhaMmtXTzNGNERpMkVMeDVodkVqXzcwcF95bnV1ekM5T1RoNVRDa09zRUVrSGIwbVJHMEhfZWRfTHlZdmx4ZlFHUEoxbnNfckhPMWVWMnJIWTJfeVNSYnc?oc=5", "source_name": "Reuters", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOR0tRSFlubTJ5dXh6M3dhMV9mUUFBUUNJa1RBSnIzMGdqNkNscFgwSUl1UzRCUWI4am5NTXJmbWtVUFZqcjVTc2htRzNnYldWMUpjU2JaQjB4QjVEc1ZtcG9vQUxLQ0dDT3hqbE5zTFAyczd3OW0wLTdsR3ZIXzJocUlSSmFTY1JCVnJBX0taakNfU29uTXNhbTRXRFVKTE9Rcmgyc0YwQk5JY0h5QkxETjdhQ1hseEE3UFJRUGxZdnNDM1BiY0lpZzhFME9YanhZMWw1U05n0gHbAUFVX3lxTE1rZktXWXhqQVIxck9jOVdJTkpYYThNa0dvMkdBdWM3V3daZVhqOVhiN19nWTRpS3YwRDBfQkNYYUtvTlE4V0FZaDJDRmhycjJnVG01dnJmdEZWUUMxT2hMTjlvM0JPb0tfY1FSY3o0MDZuclFQVUwxd3lVWFk4cnU4RFAtY0ZBQm4xbW1GRjFKRUd0QTlwUm5PNFFBaEpKVDhqeDZIcmFHQXktTUJFejloT1FlclZPOFZUU0c4RlYzc0JJNXNSMDQ3OGFoR1F4RmZwOEU4TTF6U3U1NA?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-04T08:00:00+00:00", "published_display": "04 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors", "summary": "Edwards Lifesciences Corp. (EW) shares fell by 3.13% to $87.27 on Wednesday, marking its third consecutive day of losses. This underperformance occurred despite an overall favorable trading session where the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) both saw gai", "url": "https://www.marketwatch.com/data-news/edwards-lifesciences-corp-stock-underperforms-wednesday-when-compared-to-competitors-bd4046aa-46fd7680d512?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-15T20:39:57", "published_display": "15 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mizuho Adjusts Price Target on Edwards Lifesciences to $105 From $100, Maintains Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mizuho-adjusts-price-target-edwards-152435167.html", "source_name": "MT Newswires", "published_at": "2026-07-15T15:24:35+00:00", "published_display": "15 Jul 2026 15:24", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences served $10m penalty over JC Medical acquisition violations", "summary": "", "url": "https://finance.yahoo.com/m/d131a60f-5e0b-3f39-b18c-f9d6bfc55b2e/edwards-lifesciences-served.html", "source_name": "Medical Device Network", "published_at": "2026-07-14T16:32:16+00:00", "published_display": "14 Jul 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day", "summary": "Edwards Lifesciences Corp. (EW) shares fell 1.85% to $90.09 on Tuesday, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index rose 0.38% and the Dow Jones Industrial Average rose 0.02% in an other", "url": "https://www.marketwatch.com/data-news/edwards-lifesciences-corp-stock-outperforms-competitors-despite-losses-on-the-day-ca47763c-ea3fba3c900d?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-07-14T16:49:00", "published_display": "14 Jul 2026 16:49", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Adjusts Price Target on Edwards Lifesciences to $94 From $87, Maintains Neutral Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/baird-adjusts-price-target-edwards-114527662.html", "source_name": "MT Newswires", "published_at": "2026-07-14T11:45:27+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $102 From $98, Maintains Buy Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/goldman-sachs-adjusts-price-target-113955203.html", "source_name": "MT Newswires", "published_at": "2026-07-14T11:39:55+00:00", "published_display": "14 Jul 2026 11:39", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock reflects its specialized heart-care profile", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQSGZnRlhaUGhGVV85QzdKMDFlNHBuYjVHUXNPQWEzSlktS21BWnctdExfNlBxMEZMdlI5eFY5TDBJOFpwOHo5UnBLZkk2X3JaR1FUUmx6TFUyOHc4ZFVycVN4cDV3dEdDaEdnWXFrMUFLbzBFZmRCUkoyRkg5TGRUMzFyUnZybDJpR2tzT1h3VHE1Ykk2WW1lYm9LemF2SllZWmJpaUZ2MFY1NnlpNGUtWjVVYmh6emh5TnRRa29MdnltMEQ2cnJpTg?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-14T10:50:26+00:00", "published_display": "14 Jul 2026 10:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences, Genesis MedTech to Pay Combined $12M to Settle FTC Charges -- Update", "summary": "Edwards Lifesciences and Genesis MedTech will pay a combined $12 million to settle Federal Trade Commission (FTC) charges related to their previous acquisition activities. The FTC alleged that Edwards Lifesciences acquired Genesis MedTech's heart valve business in 2022, which was", "url": "https://www.moomoo.com/news/post/72881238/edwards-lifesciences-genesis-medtech-to-pay-combined-12m-to-settle?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-13T23:07:59", "published_display": "13 Jul 2026 23:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Edwards Lifesciences Corp For: 13 July By Investing.com", "summary": "This article reports on a Form 4 filing for Edwards Lifesciences Corp (EW) on July 13. Form 4s indicate changes in ownership of company stock by insiders. The article provides the date of the filing but does not detail the specifics of the transactions.", "url": "https://ng.investing.com/news/stock-market-news/form-4-edwards-lifesciences-corp-for-13-july-93CH-2597468", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T21:18:04", "published_display": "13 Jul 2026 21:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards will pay $10M to settle FTC charges of skirting antitrust review", "summary": "", "url": "https://finance.yahoo.com/m/75731ca0-1aa0-3dde-a0b0-3555d48fa739/edwards-will-pay-%2410m-to.html", "source_name": "MedTech Dive", "published_at": "2026-07-13T17:02:14+00:00", "published_display": "13 Jul 2026 17:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Raises Price Target on Edwards Lifesciences to $110 From $100, Keeps Outperform Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/rbc-raises-price-target-edwards-115343357.html", "source_name": "MT Newswires", "published_at": "2026-07-13T11:53:43+00:00", "published_display": "13 Jul 2026 11:53", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock reflects steady growth prospects in cardiovascular care", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNSXI5Y3VnTlpMd3RqcVlJOE1SWEo3d0ZFbHd6NkhjQ09TZWhEYzItOGR3VF9NVWx1ZFd4S3UyZ2dhclJwTjloTm1PZDlxWVdVYXZwT2RaNk8xbzhsaVBWekhIZ0c0ODhqdV9JUlZhTEJjbDZWRUp1RE8tbF84aV9mUmtLZkR2czJucWExRWtQVlctcUFteVNkRFZ4SkNQeWp2clJIbG1INk9SQWt1ZXpyT1p5ZjNsT005R3JOS0NR?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-11T22:01:51+00:00", "published_display": "11 Jul 2026 22:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW)", "summary": "Daniel Lippis, CVP, TAVR at Edwards Lifesciences Corp (EW), sold 619 shares of the company on July 10, 2026. This transaction leaves him with 40,033.9103 shares. The article also notes that Edwards Lifesciences Corp is currently trading at $91.7, which is fairly valued according ", "url": "https://www.gurufocus.com/news/8954306/insider-sell-daniel-lippis-sells-shares-of-edwards-lifesciences-corp-ew", "source_name": "GuruFocus", "published_at": "2026-07-11T00:46:40", "published_display": "11 Jul 2026 00:46", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Edwards Lifesciences Corp For: 10 July By Investing.com", "summary": "This article reports on a Form 4 filing for Edwards Lifesciences Corp for transactions made on July 10th. Form 4s disclose changes in beneficial ownership of securities by company insiders. The brief news item includes the company's stock symbol (EW) and its performance on the da", "url": "https://ng.investing.com/news/stock-market-news/form-4-edwards-lifesciences-corp-for-10-july-93CH-2595637", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T21:37:40", "published_display": "10 Jul 2026 21:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences CVP sells $56,762 in company stock", "summary": "Daniel J. Lippis, CVP of TAVR at Edwards Lifesciences Corp (NASDAQ:EW), sold 619 shares of company stock for $56,762 after acquiring them through employee stock options. The transactions were conducted under a Rule 10b5-1 trading plan. Following the sale, Mr. Lippis retains over ", "url": "https://www.investing.com/news/insider-trading-news/edwards-lifesciences-cvp-sells-56762-in-company-stock-93CH-4786998", "source_name": "Investing.com", "published_at": "2026-07-10T21:37:35", "published_display": "10 Jul 2026 21:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) CFO receives stock, performance unit and option grants", "summary": "The CFO of Edwards Lifesciences, Theodora Mistras, received new equity awards on July 9, 2026, as part of the company's Long-Term Stock Incentive Compensation Program. These awards include restricted stock units, performance-based restricted stock units, and employee stock option", "url": "https://www.stocktitan.net/sec-filings/EW/form-4-edwards-lifesciences-corp-insider-trading-activity-25726b83c6f1.html", "source_name": "Stock Titan", "published_at": "2026-07-10T21:11:36", "published_display": "10 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) CVP exercises stock options and sells 619 shares", "summary": "Daniel J. Lippis, CVP at Edwards Lifesciences, exercised stock options for 619 shares at $72.68 and immediately sold them at $91.70 per share on July 10, 2026. This transaction was pre-scheduled under a Rule 10b5-1 trading plan adopted in February 2026. Following these trades, Li", "url": "https://www.stocktitan.net/sec-filings/EW/form-4-edwards-lifesciences-corp-insider-trading-activity-f6e5a6847b18.html", "source_name": "Stock Titan", "published_at": "2026-07-10T21:04:34", "published_display": "10 Jul 2026 21:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors", "summary": "Edwards Lifesciences Corp. (EW) stock fell 2.47% on Thursday, closing at $91.33. This underperformance occurred despite a favorable trading session for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both rising. This marks the third consecutive day of", "url": "https://www.marketwatch.com/data-news/edwards-lifesciences-corp-stock-underperforms-thursday-when-compared-to-competitors-aded3bc0-0220a69ba00e", "source_name": "MarketWatch", "published_at": "2026-07-09T20:47:47", "published_display": "09 Jul 2026 20:47", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxObXdOUUozb2RKbXgxcVpKb0c0eVdkWDBqYzQybW1QcE1QSkZZYW1HbmVqMHczT083VENoa2QzNkU1WGprRjRKU2d5MDM1VFRqRVpfZk83VG1vSVl4cURlM3JTUmdWVHFmck5SNmRpUThJRl9GREd6UXJXUWpWdEhhNV9sb0d0WWlBTU5JZjNJS25LZzJCNXJDeDJtN3JKaU1FREhKOF9UVXRqb3dLbDZZdnJQNGZadkVUUmNUS1BfU3hIZTdPWC1OdVhn?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T10:40:27+00:00", "published_display": "09 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EW Maintained by Citigroup -- Price Target Raised to $110", "summary": "Citigroup has maintained a \"Buy\" rating on Edwards Lifesciences (EW) and raised its price target from $101 to $110, indicating confidence in the company's growth opportunities. Despite this positive analyst outlook and a strong GF Score\u2122 of 97/100, the stock is currently consider", "url": "https://www.gurufocus.com/news/8949685/ew-maintained-by-citigroup-price-target-raised-to-110", "source_name": "GuruFocus", "published_at": "2026-07-08T17:07:30", "published_display": "08 Jul 2026 17:07", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) Shares Fresh Valve Data, Is The Stock Too Pricey?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T16:01:20+00:00", "published_display": "08 Jul 2026 16:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citigroup Adjusts Edwards Lifesciences Price Target to $110 From $101", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/citigroup-adjusts-edwards-lifesciences-price-131704289.html", "source_name": "MT Newswires", "published_at": "2026-07-08T13:17:04+00:00", "published_display": "08 Jul 2026 13:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences focuses on heart valve growth as US cardiac demand stays solid", "summary": "Edwards Lifesciences, a medical technology company, is prioritizing growth in heart valve therapies, especially TAVR, driven by solid demand in the US cardiac procedure market and an aging population. The company's strategy revolves around treating structural heart diseases with ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/edwards-lifesciences-focuses-on-heart-valve-growth-as-us-cardiac-demand/69723943", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T13:08:46", "published_display": "08 Jul 2026 13:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences\u2019 SWOT analysis: stock gains momentum on market share opportunity", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxNMXA2MGJhcXQ1UVZNOWNoVDlxbTM5ZnBsMzFfNHE2SFBRcFhHOUl3X1U1anVrNF9tYlBXQXo4UnpwT2EzdXhDT3dOOVZXa0lsM2pvSDBGbTM0RWFOakZkRExlbTdPbko2S2lYNExWU3RlLW1xSmZZYnRUSm9NMVg2YUNVQ1lPX0xQRzBoRkV4UnBPVk5aMDJrRUxmaWQtZk1JRjVRaVFCb1FNa0hWak9pZTUyaHF6T3pKZEtXZFRsTldDeU5QN3hpR2tCTWhfb1h3UTZJb1FhTFI?oc=5", "source_name": "Investing.com", "published_at": "2026-07-07T23:13:02+00:00", "published_display": "07 Jul 2026 23:13", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Edwards Lifesciences Corp For: 7 July By Investing.com", "summary": "This article from Investing.com announces the filing of a Form 4 for Edwards Lifesciences Corp on July 7th. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders when they trade shares in their own company. This filin", "url": "https://ng.investing.com/news/stock-market-news/form-4-edwards-lifesciences-corp-for-7-july-93CH-2590079", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T00:02:00", "published_display": "08 Jul 2026 00:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) executive has shares withheld for tax on vesting", "summary": "Edwards Lifesciences executive Daniel J. Lippis reported a routine disposition of 377 shares of common stock at $95.18 per share. This action was taken to cover tax obligations related to the vesting of equity awards, as per Rule 16b-3(e). After this tax-withholding event, Lippis", "url": "https://www.stocktitan.net/sec-filings/EW/form-4-edwards-lifesciences-corp-insider-trading-activity-10380872e16c.html", "source_name": "Stock Titan", "published_at": "2026-07-07T22:56:40", "published_display": "07 Jul 2026 22:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences highlights structural heart portfolio as investors track long-term growth prosp", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOdUcxR1cxa3BuRWFDaElVeEtpLXNQa0lFc29IYXVlZ3laT3kyVXF1cGVTVkdXYjlpMjRrV29DbkFfMXRTdHM1WmV0VUxqb3FKX2RLdmNfeW9kbFN4eHZyYkYxMnpfclZsUzZtRGNEMEZWcUtIT3FPQy1YXzZ0UmpTN3ZpOHdBR2phNU1pdzlFdVVHbnVzZHJOcWc5Wi1NZ3lEY0l0NmRQdElaZ1ZabEF4ckEwTXQ0b1pLMVlETGhCWm1yVmlRemRFUkhB?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-07T06:57:48+00:00", "published_display": "07 Jul 2026 06:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Adjusts Price Target on Edwards Lifesciences to $100 From $93", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-adjusts-price-target-131101622.html", "source_name": "MT Newswires", "published_at": "2026-07-06T13:11:01+00:00", "published_display": "06 Jul 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock leans on its core heart valve business", "summary": "Edwards Lifesciences (US28176E1082) remains focused on its structural heart therapies, particularly its core heart valve franchise. The company's business model relies on transcatheter aortic valve replacement systems and related products, with the SAPIEN family being a key produ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/edwards-lifesciences-stock-leans-on-its-core-heart-valve-business/69703313", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T08:23:52", "published_display": "06 Jul 2026 08:23", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EW - Edwards Lifesciences Corp Volatility & Greeks", "summary": "This article provides a detailed financial overview of Edwards Lifesciences Corp (EW), including its stock performance, market capitalization, income, sales, and various financial ratios. It also presents insider ownership and institutional ownership data, along with volatility m", "url": "https://finviz.com/stock?t=EW&ty=ocv&ta=1&p=d&ov=list_date&e=2026-08-21", "source_name": "Finviz", "published_at": "2026-07-05T22:08:51", "published_display": "05 Jul 2026 22:08", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How New Valve Trial Data and Index Reclassification Will Impact Edwards Lifesciences (EW) Investors", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T08:39:36+00:00", "published_display": "05 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Edwards Lifesciences Corp (EW)", "summary": "This article analyzes the historical performance of investing $1,000 in Edwards Lifesciences Corp (EW) over various periods, showing returns ranging from +23.1% in one year to +184.2% over ten years. It also provides a detailed overview of Edwards Lifesciences, a medical technolo", "url": "https://www.stocktitan.net/tools/stock-return-calculator/EW", "source_name": "Stock Titan", "published_at": "2026-07-04T08:37:38", "published_display": "04 Jul 2026 08:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences focuses on heart valve growth. Investors watch structural heart demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQYTFMaXpwQzR5dEZCckJoSERDaU1udGVvVVRSNVlIYVpabk5nVGs5M2lGZEx3ZUgxM0pwUWhmS3BzZnp6OW94REtNZWdadEFRZ2MwSnFoblNQekpkQ3gtRjE5cUtoOGJTcE1TWWNVeXM1dFU5RXFlRWI1aGVqLWlZWWlnaWQyU1V3U3RJd3J5MnZtR1JoQjRlYlZnM251VlRLaFFaeVVoS3hCRWJlNFV0SXd5TmwwLVZfZzQxbGw1U25iV2s?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T10:50:42+00:00", "published_display": "03 Jul 2026 10:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOLU0tWE5MT21oOEJ1YlhNbzgzYTBRM0szdFkxTi0zQTdKUk9VUnI5Z0wwbW9sZHR2Z1VscTkyTE9vc1ViVHRyekRPc2g2dmpVeWstcGs0RkZVZW9UVURIQkdtZEVEVFV5ZXR1RWMwelZkXzBpNVJsUlNxTEpLUnpjaTAwRmxHY3pYQzVtNnRjNF9yaC1IVWhZa1NqOEUtaFlyN0JHNkpqblZ2Y0VkQmZfVTM4RUwyWkN2?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) Stock Weighs DCF Fair Value Against High P/E Multiple", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards brings fresh valve data to New York, with TAVR study update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQ2pGVVRySmVSeUVWVVFwZngxdkQ3UE82Y3E1RmtYZFZVc2Y0eXVpVnVwZTBKenZ2Ti1VM1BncV9zWWdqTDQwUnlFUDktN01UTExBTjNNV0ppQUtEVUtLTVpMUVMyTmdPV2ZLTFVRSldGR3MzS241VmVOTE9ubC1fSEwyZENJd3Zzck0wbVNNV19PaFJhTkc0S2trLXh5bXF3eklYUlM4SXVNczVucXM0OHVPVWpPUWl0NFZj?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Edwards Lifesciences stock climbing today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPN3NTd2lKT3RnTjJoUl9aRUhfbi13U3ZEdHBaaDhjSS0tQ2NxeU5RVERGNTJlNHpCVzFGWVpLb25wUWUteXgzemViTVFCVDlxcDluQnRJT2JZcFFkcm15T2dvTTdXXzFpVlRfWHhTcFBhVG1YVTZoNTlJWTk0dG53M2VibE00Q0ZqY0trYV9lZjBYYUx0ZlFIVlExQWNYX2Etd1A1NHhzRlJiaDhFMldz?oc=5", "source_name": "Investing.com", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences Stock (US28176E1082): Valuation metrics under the microscope", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQbWpXRkstZjUzYU5GVVRtS3hYNDZ0dXhlb0FaS1FWU3VCWU5pNXJKd1lVRWMyVlRSajJ0Slp2NWhGalJqQ3dpVnc1OFhJV3ZiMU5vZElkWHh4Zi0yNW5fZ05UMk1wMW1VbFpMbkVuRDRhUTBpOXROd3g0ZGczaGp4MTQ1MEg4bDBXQ1N1WHlXZEpmX1EtbjNRN2tKaEpLcU84YmR0UkxEV1U1c0twMEVlOTdXYTEwNEMwREtNN3A0UzRvd1hf?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPSFNyMnNsYWo0VFpRRm15ekVtRDNXbHE0ZHZpQUtWS1o3RUJxZUtDcEdWUzc1VHlEd04tdW80WGpITUwwazlhNGhiS0tVa3NvaXdMQ25JWDZQdXNsRWVyclFDUzZPaGp3RzRZNGdBRGpMdlZpZk53akRCbVBFLWlKQzJQSkZBUTA4cTk3TmZ5S0d0TkRmQmpKSGFKQWNRN2hEUGltX2U4Q1lKdTNKUVNv?oc=5", "source_name": "Market source", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock (US28176E1082): NYSE-listed medtech share edges lower as investors digest", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPQ21HWW9tRm04NVhGSGg3aF96T2s5dXhLQ3EwNjJsVDc2UE5xV0pwZGdaVkw5U3F0c05ZdlJGNGNmV3lIRWhvVE9LS1dJdkx2U0RoS2dmWGlkbTZpd3liYy1BaGh6M19sMTVJSnpVZHc1anZWa2N0Y2xLMVJfdk4tT1ByUnpkMjFvb2hkUkVJbHd2NWx4Z0hPaXMxQ0MybXNZLVNkVEhfTUNWZjZyLVZLN1hPZDRLUGtQaHhmSzVkWXNoczExWGwyLWF3?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Strength?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPM3FMVXZjanB3aFlDNV9ad29xWDM3OUJHd0dtTGFaRnhvOTRndUlQR2Iwb3lyT2tYSDZ4T1g2eFNCdHp1UFM0Z1RENlNxWk8yZnFRdUtzemQxYlJocXdQUzZwOUFyV3p6U2U3OVpPeU5xRXpuYXJ2ZGJqcURLWTdnOF9tNGxZMkd3dTREUUZ5ZjZvdUhKcTFpX2ZXcDZDWGdvZmxINg?oc=5", "source_name": "Market source", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock (US28176E1082): heart-valve specialist in focus after latest earnings upd", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPTkhWajJYRzFZY20tSms3Y1BaT0NtSjh6MWJjVl9RWi1GZVhxVVdILWFvS0pXcHV6NDBibkpPNS00eG5fd2Z4X0pJa2ZjdnZ0LVVPZ0g2cEJWQXVUZmJRMDVLRUFDcEtjVDhQMEluTFdCaVh4cmNaSUJ2Vkd6Z2ZfM2FXNzhON0NBaG5PelR0U183a3JMVFhOUGdEaGRFOExOdXQ1TnNDNHhfblZLaGkwQUhIMmE3TG9ZT19sWEN5Q2MyVl81RTI3aFV3?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPNHk2djRZbXd0ekVhdWpfZ1FPamYwU0tMQy1mT3N4Tm9hWnJ3NzRJMVNjMnFJVHRIU1NzV1h3VTFwVEtDN0ZNV1hEMHVtdkk0VTI1ckNweUR5eHduSnFlb0Y3bFJDNlVnY2ZsSGhNY1IwZ1I0Q1hORHFaVEE1R1FXRWxMUmtjOWdUTjJuWUw3QktMRXQwa1RyaXkycVE1Q19VTzJoa0tEbndUa00?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOdTBGTnJfMDl5NUNzRDZ0LTFEME9nRFBwXzM1RERqRXphUjg3c19BZ3lJSV9wU0FvTVBpVWdfZm1lRmZ5TGtxWXplNmRrRFEzTkJKUHFqMkhaMmtXTzNGNERpMkVMeDVodkVqXzcwcF95bnV1ekM5T1RoNVRDa09zRUVrSGIwbVJHMEhfZWRfTHlZdmx4ZlFHUEoxbnNfckhPMWVWMnJIWTJfeVNSYnc?oc=5", "source_name": "Reuters", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-04T08:00:00+00:00", "published_display": "04 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 112, "total_relevant": 56, "sentiment_summary": {"positive": 12, "negative": 5, "neutral": 39, "score": 52, "total": 56, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 18.1, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 5.64, "count": 13}, {"event": "analyst", "label": "Analyst action", "weight": 3.85, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 2.0, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}], "positive_events": 12, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 92.21, "latest_week": "2026-07-10", "one_week_move": -2.3, "four_week_move": 8.3, "twelve_week_move": 13.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.157294, "market_dynamics_buy_signal": false, "relative_strength": 0.955033, "fair_value_gap": 18.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 36.8331, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.3% over one week, +8.3% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Ad-hoc-news.de", "count": 8}, {"label": "MT Newswires", "count": 6}, {"label": "Stock Titan", "count": 6}, {"label": "simplywall.st", "count": 4}, {"label": "MarketWatch", "count": 3}, {"label": "Investing.com Nigeria", "count": 3}, {"label": "Investing.com", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 13}, {"label": "Analyst action", "count": 7}, {"label": "Deals and strategy", "count": 3}, {"label": "Macro sensitivity", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-2.3% over one week, +8.3% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors"}], "updated_at": "2026-07-15T23:34:27.636521+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}